Bio-Techne shareholders approve Merck KGaA acquisition
Bio-Techne shareholders voted to approve the merger agreement under which Merck KGaA, Darmstadt, Germany would acquire the life science tools maker for cash.
Read the full coverage, free
We only link to sources you can read without a subscription. How we check.